Gyawali, B., Hey, S. P., & Kesselheim, A. S. (2020). Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs. EClinicalMedicine.
Styl cytowania ChicagoGyawali, Bishal, Spencer P. Hey, i Aaron S. Kesselheim. "Evaluating the Evidence Behind the Surrogate Measures Included in the FDA's Table of Surrogate Endpoints As Supporting Approval of Cancer Drugs." EClinicalMedicine 2020.
Styl cytowania MLAGyawali, Bishal, Spencer P. Hey, i Aaron S. Kesselheim. "Evaluating the Evidence Behind the Surrogate Measures Included in the FDA's Table of Surrogate Endpoints As Supporting Approval of Cancer Drugs." EClinicalMedicine 2020.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..